Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Somnomed Limited (SOMNF) Stock Price & Analysis

SOMNF Stock Chart & Stats

$0.18$0.00(0.00%)
At close: 4:00 PM EDT
$0.18$0.2$0.22$0.2411 Sep27 Oct
Day’s Range
$0.16 - $0.18
52-Week Range
$0.16 - $0.56
Previous Close
$0.18
Volume
17.00K
Average Volume (3M)
133
Market Cap
$44.82M
Enterprise Value
$102.25M
Total Cash (Recent Filing)
$17.18M
Total Debt (Recent Filing)
$5.46M
Price to Earnings (P/E)
―
Beta
0.90
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Cash Generation And Balance Sheet

Positive operating and free cash flow, combined with conservative leverage, gives SomnoMed greater financial flexibility to fund capacity, product development and market expansion internally. The improved balance sheet also reduces dependence on external financing while operations continue recovering.

North America Growth

North America is identified as the primary growth region and delivered the strongest regional performance, providing an important engine for future expansion. Continued adoption there could help offset weaker markets and support revenue scale while the company maintains improving operating margins.

Virtus Product Innovation

Virtus expands SomnoMed’s offering toward an underserved obstructive sleep apnoea segment with a significant bruxism overlap. Positive early feedback supports the product’s commercial potential, while broader adoption could strengthen differentiation and create an additional source of durable growth.

Bears Say

Persistent Net Losses

Despite improving EBIT and EBITDA, SomnoMed remains loss-making at the net income level and does not yet generate positive returns on shareholder capital. Continued losses can limit internally funded growth, weaken earnings quality and delay the conversion of operational improvement into durable shareholder returns.

European Reimbursement Headwinds

Europe is SomnoMed’s largest region, so structural reimbursement and access changes represent a material threat to demand and clinician referral flows. The resulting commercial and leadership restructuring may take time to produce benefits, leaving regional growth and overall revenue consistency under pressure.

Connected Care Uncertainty

The unresolved FDA process and unclear Connected Care commercialization timetable create uncertainty around a potentially important product extension. Delays could defer expected strategic benefits, require further investment and make it harder for investors to assess the timing and scale of future growth.

Somnomed Limited News

SOMNF FAQ

What was Somnomed Limited’s price range in the past 12 months?
Somnomed Limited lowest stock price was $0.16 and its highest was $0.56 in the past 12 months.
What is Somnomed Limited’s market cap?
Somnomed Limited’s market cap is $44.82M.
When is Somnomed Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Somnomed Limited’s earnings last quarter?
Somnomed Limited released its earnings results on Aug 27, 2026. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of $0.003 by -$0.01.
Is Somnomed Limited overvalued?
According to Wall Street analysts Somnomed Limited’s price is currently Undervalued.
Does Somnomed Limited pay dividends?
Somnomed Limited does not currently pay dividends.
What is Somnomed Limited’s EPS estimate?
Somnomed Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Somnomed Limited have?
Somnomed Limited has 219,768,250 shares outstanding.
What happened to Somnomed Limited’s price movement after its last earnings report?
Somnomed Limited reported an EPS of -$0.007 in its last earnings report, missing expectations of $0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Somnomed Limited?
Currently, no hedge funds are holding shares in SOMNF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology